Two Sigma Securities’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-874
| Closed | -$7.59K | – | 1744 |
|
|
2023
Q2 | $7.59K | Sell |
874
-27
| -3% | -$235 | ﹤0.01% | 1114 |
|
|
2023
Q1 | $13K | Buy |
+901
| New | +$13K | ﹤0.01% | 1126 |
|
|
2022
Q1 | – | Sell |
-1,478
| Closed | -$41K | – | 1394 |
|
|
2021
Q4 | $41K | Buy |
+1,478
| New | +$41K | ﹤0.01% | 810 |
|
|
2021
Q2 | – | Sell |
-1,815
| Closed | -$111K | – | 913 |
|
|
2021
Q1 | $111K | Buy |
+1,815
| New | +$111K | 0.01% | 462 |
|
|
2020
Q2 | – | Sell |
-1,001
| Closed | -$55K | – | 855 |
|
|
2020
Q1 | $55K | Buy |
1,001
+849
| +559% | +$46.6K | ﹤0.01% | 506 |
|
|
2019
Q4 | $13K | Buy |
+152
| New | +$13K | ﹤0.01% | 728 |
|
|
2019
Q1 | – | Sell |
-224
| Closed | -$21K | – | 1213 |
|
|
2018
Q4 | $21K | Buy |
+224
| New | +$21K | ﹤0.01% | 1020 |
|
|
2018
Q3 | – | Sell |
-149
| Closed | -$24K | – | 1448 |
|
|
2018
Q2 | $24K | Buy |
+149
| New | +$24K | ﹤0.01% | 971 |
|
|
2018
Q1 | – | Sell |
-126
| Closed | -$21K | – | 1418 |
|
|
2017
Q4 | $21K | Buy |
+126
| New | +$21K | ﹤0.01% | 923 |
|
|
2017
Q3 | – | Sell |
-855
| Closed | -$144K | – | 1060 |
|
|
2017
Q2 | $144K | Buy |
855
+587
| +219% | +$98.9K | 0.03% | 611 |
|
|
2017
Q1 | $28K | Buy |
+268
| New | +$28K | 0.01% | 832 |
|